BDX: Becton Dickinson & Co Growth-Adjusted Market Cap to Net Income

Becton Dickinson & Co (BDX) relies on stable demand for medical supplies that remains independent of economic downturns. The weighted price-to-earnings-to-growth ratio in the GURU.Markets terminal contains current dynamics, where the value 2.39 describes the current level, confirming the brand's status as a global benchmark for quality. The global resilience of the business is supported by a neutral geopolitical backdrop and secure supply chains.

Becton Dickinson & Co (BDX) revenues depend directly on hospitalization volumes and government funding for medical technology, which creates volatility in profit growth rates. This metric compares the current market P/E multiple with the net income growth rate, allowing the P/E-to-growth chart to determine the asset's fair value and identify undervaluation when the value falls below one.